Explore it now
27th Annual ESGO 2026 Congress
Discover it Now!
ENGOT coordinates and promotes gynaecological cancer clinical trials in Europe
Explore ENGOT
Explore ESGO’s Membership Benefits
Read More
In 2024, ESGO launched an advocacy initiative to strengthen its voice in European health policy and champion the needs of women affected by gynaecological cancers.
By engaging with the EU at a political level, ESGO will advocate for improved standards of care, better access to treatment, increased research funding, and the establishment of a network of centres of excellence across Member States.
ESGO will continue to expand its advocacy efforts, fostering collaboration with like-minded societies based in Brussels and ensuring that gynaecological oncology remains a prominent focus on the EU health agenda.
Vice President Ass. Prof. Maja Pakiz participated in an exchange of views with the European Parliament’s Committee on Public Health (SANT) on 14 May, calling for stronger and more coordinated EU-level action to address the persistent gaps in care, research, and policy surrounding ovarian and other gynaecological cancers.
View Press Release